Surgery at specialised sarcoma centres improves patient outcomes – A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party

• Published in: European journal of surgical oncology Vol. 49; no. 9; p. 106951
• Main Authors: Hong, Angela M., Sundaram, Abay, Perianayagam, Ganaps, Lo, Helen, Lawless, Anna, Zhou, Deborah, McDonough, Joshua, Thompson, Stephen R., Maclean, Fiona, Connolly, Elizabeth A., Coker, David, Mar, Jasmine, Lazarakis, Smaro, Johnston, Andrew
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.09.2023
• Subjects: Bone sarcoma; Limb salvage; Sarcoma; Soft tissue sarcoma; Specialised centre; Surgery; Soft tissue sarcoma; Bone sarcoma; Limb salvage; Sarcoma; Specialised centre; Surgery
• ISSN: 0748-7983; 1532-2157
• DOI: 10.1016/j.ejso.2023.06.003

Optimal management of sarcoma requires multidisciplinary team input throughout the process of diagnosis, treatment and follow up. This systematic review aimed to evaluate the impact of surgery performed at specialised sarcoma centres on outcomes. A systematic review was conducted using the population, intervention, comparison and outcome (PICO) model. Medline, Embase, Cochrane Central databases were queried for publications that evaluated the local control, limb salvage rate, 30-day and 90-day surgical mortality, and overall survival in patients undergoing surgery in a specialist sarcoma centre compared with non-specialist centre. Each study was screened by two independent reviewers for suitability. A qualitative synthesis of the results was performed. Sixty-six studies were identified. The majority of studies were Level III-3 as assessed by the NHMRC Evidence Hierarchy, whilst just over half of the studies were of good quality. Definitive surgery performed at specialised sarcoma centres was associated with improved local control as defined by lower rate of local relapse, higher rate of negative surgical margins, improved local recurrence free survival and higher limb conservation rate. Available evidences show a favourable pattern of lower 30-day and 90-day mortality rates, and greater overall survival when surgery was performed in specialist sarcoma centres compared with non-specialised centres. Evidences support better oncological outcomes when surgery is performed at specialised sarcoma centre. Patients with suspected sarcoma should be referred early to a specialised sarcoma centre for multidisciplinary management, which includes planned biopsy and definitive surgery.